Global Healthcare CRO Services Market
Global Healthcare CRO Services Market

Healthcare CRO Services Comprehensive Study by Type (Early Phase Development Services {Discovery Studies, Chemistry, Manufacturing & Control, Preclinical Services (Pharmacokinetics /Pharmacodynamics, Toxicology Testing, Other), Clinic Research Services {Phase I, Phase II, Phase III, Phase IV}, Laboratory Services {Bioanalytical Testing, Analytical Testing (Physical Characterization, Stability Testing, Batch Release Testing, Raw Material Testing, Other Analytical Testing)}, Consulting Services, Data Management Services), Therapeutic Areas (Oncology, CNS Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunological Disorders, Respiratory Disorders, Diabetes, Other), End User (Pharmaceutical and Biopharmaceutical Companies, Medical Device Companies, Academic Institutes) Players and Region - Global Market Outlook to 2026

Healthcare CRO Services Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026 | CAGR: 7.28%  

May 2021 Edition 236 Pages 213 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Global Healthcare CRO Services Market Overview:
Healthcare CRO Services provide services in form of research facilities outsourced on contract basis to research organizations, academic institutes, and government organizations. These services include drug development, assay development, commercialization, preclinical & clinical research, clinical trials management, and pharmacovigilance. The increasing outsourcing of R&D activities and high failure rate of clinical trials has increased the demand for healthcare CRO services. According to AMA, the Global Healthcare CRO Services market is expected to see growth rate of 7.28%

Growth Drivers
  • Increasing R&D Investment in Clinical & Non-Clinical Research Activities
  • Increasing Demand Of Outsourcing Analytical Testing And Clinical Trial Services

Market Trends
  • Growing Consolidation in the CROs Industry

Roadblocks
  • Regulatory Pressure on CRO Service Providers

Opportunities
  • Untapped Emerging Economies
  • Growing Biosimilars and Biologics Market
  • Rising Demand for Specialized Testing Services

Challenges
  • Lack Of Skilled Healthcare Professionals


Competitive Landscape:

Some of the key players profiled in the report are IQVIA Holdings, Inc. (United States), Laboratory Corporation of America Holdings (United States), Pharmaceutical Product Development, Inc.(United States), Parexel International Corporation (United States), Charles River Laboratories International, Inc. (United States), ICON PLC (Ireland), Medidata Solutions, Inc.(United States), Syneos Health, Inc. (United States), Pharmaron Beijing Co., Ltd. (China), GVK Biosciences Private Limited (India), SGS SA (Switzerland), EPS International Co., Ltd (Japan) and Genscript Biotech (United States). Analyst at AMA Research see United States Players to retain maximum share of Global Healthcare CRO Services market by 2026. Considering Market by Therapeutic Areas, the sub-segment i.e. Oncology will boost the Healthcare CRO Services market. Considering Market by End User, the sub-segment i.e. Pharmaceutical and Biopharmaceutical Companies will boost the Healthcare CRO Services market.

Latest Market Insights:
In October 2019, ICON acquired Symphony Clinical Research, a global leader in a clinical research company. This acquisition enables ICON to minimize travel burden for patients by providing them access to clinical research studies.

In March 2020, Medidata signed an agreement with Medpace Inc. for integrating Medidata Rave Imaging with Medpace's imaging systems and workflow. The integration is expected to create a seamless platform for capturing, managing, analyzing, and storing images and imaging data for clinical trials.

Available Customization:
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be provided prior to purchase

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Healthcare CRO Services market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Healthcare CRO Services market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes New Entrants/Investors, Analysts and Strategic Business Planners, Healthcare CRO Services Providers, Venture Capitalists and Private Equity Firms, Government Regulatory and Research Organizations and End Use Industry.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.
Report Objectives / Segmentation Covered
By Type
  • Early Phase Development Services {Discovery Studies, Chemistry, Manufacturing & Control, Preclinical Services (Pharmacokinetics /Pharmacodynamics, Toxicology Testing, Other)
  • Clinic Research Services {Phase I, Phase II, Phase III, Phase IV}
  • Laboratory Services {Bioanalytical Testing, Analytical Testing (Physical Characterization, Stability Testing, Batch Release Testing, Raw Material Testing, Other Analytical Testing)}
  • Consulting Services
  • Data Management Services
By Therapeutic Areas
  • Oncology
  • CNS Disorder
  • Cardiovascular Disease
  • Metabolic Disease
  • Infectious Disease
  • Immunological Disorders
  • Respiratory Disorders
  • Diabetes
  • Other

By End User
  • Pharmaceutical and Biopharmaceutical Companies
  • Medical Device Companies
  • Academic Institutes

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing R&D Investment in Clinical & Non-Clinical Research Activities
      • 3.2.2. Increasing Demand Of Outsourcing Analytical Testing And Clinical Trial Services
    • 3.3. Market Challenges
      • 3.3.1. Lack Of Skilled Healthcare Professionals
    • 3.4. Market Trends
      • 3.4.1. Growing Consolidation in the CROs Industry
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Healthcare CRO Services, by Type, Therapeutic Areas, End User and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Healthcare CRO Services (Value)
      • 5.2.1. Global Healthcare CRO Services by: Type (Value)
        • 5.2.1.1. Early Phase Development Services {Discovery Studies, Chemistry, Manufacturing & Control, Preclinical Services (Pharmacokinetics /Pharmacodynamics, Toxicology Testing, Other)
        • 5.2.1.2. Clinic Research Services {Phase I, Phase II, Phase III, Phase IV}
        • 5.2.1.3. Laboratory Services {Bioanalytical Testing, Analytical Testing (Physical Characterization, Stability Testing, Batch Release Testing, Raw Material Testing, Other Analytical Testing)}
        • 5.2.1.4. Consulting Services
        • 5.2.1.5. Data Management Services
      • 5.2.2. Global Healthcare CRO Services by: Therapeutic Areas (Value)
        • 5.2.2.1. Oncology
        • 5.2.2.2. CNS Disorder
        • 5.2.2.3. Cardiovascular Disease
        • 5.2.2.4. Metabolic Disease
        • 5.2.2.5. Infectious Disease
        • 5.2.2.6. Immunological Disorders
        • 5.2.2.7. Respiratory Disorders
        • 5.2.2.8. Diabetes
        • 5.2.2.9. Other
      • 5.2.3. Global Healthcare CRO Services by: End User (Value)
        • 5.2.3.1. Pharmaceutical and Biopharmaceutical Companies
        • 5.2.3.2. Medical Device Companies
        • 5.2.3.3. Academic Institutes
      • 5.2.4. Global Healthcare CRO Services Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Healthcare CRO Services: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. IQVIA Holdings, Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Laboratory Corporation of America Holdings (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Pharmaceutical Product Development, Inc.(United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Parexel International Corporation (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Charles River Laboratories International, Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. ICON PLC (Ireland)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Medidata Solutions, Inc.(United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Syneos Health, Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Pharmaron Beijing Co., Ltd. (China)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. GVK Biosciences Private Limited (India)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. SGS SA (Switzerland)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. EPS International Co., Ltd (Japan)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. Genscript Biotech (United States)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
  • 7. Global Healthcare CRO Services Sale, by Type, Therapeutic Areas, End User and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Healthcare CRO Services (Value)
      • 7.2.1. Global Healthcare CRO Services by: Type (Value)
        • 7.2.1.1. Early Phase Development Services {Discovery Studies, Chemistry, Manufacturing & Control, Preclinical Services (Pharmacokinetics /Pharmacodynamics, Toxicology Testing, Other)
        • 7.2.1.2. Clinic Research Services {Phase I, Phase II, Phase III, Phase IV}
        • 7.2.1.3. Laboratory Services {Bioanalytical Testing, Analytical Testing (Physical Characterization, Stability Testing, Batch Release Testing, Raw Material Testing, Other Analytical Testing)}
        • 7.2.1.4. Consulting Services
        • 7.2.1.5. Data Management Services
      • 7.2.2. Global Healthcare CRO Services by: Therapeutic Areas (Value)
        • 7.2.2.1. Oncology
        • 7.2.2.2. CNS Disorder
        • 7.2.2.3. Cardiovascular Disease
        • 7.2.2.4. Metabolic Disease
        • 7.2.2.5. Infectious Disease
        • 7.2.2.6. Immunological Disorders
        • 7.2.2.7. Respiratory Disorders
        • 7.2.2.8. Diabetes
        • 7.2.2.9. Other
      • 7.2.3. Global Healthcare CRO Services by: End User (Value)
        • 7.2.3.1. Pharmaceutical and Biopharmaceutical Companies
        • 7.2.3.2. Medical Device Companies
        • 7.2.3.3. Academic Institutes
      • 7.2.4. Global Healthcare CRO Services Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Healthcare CRO Services: by Type(USD Million)
  • Table 2. Healthcare CRO Services Early Phase Development Services {Discovery Studies, Chemistry, Manufacturing & Control, Preclinical Services (Pharmacokinetics /Pharmacodynamics, Toxicology Testing, Other) , by Region USD Million (2015-2020)
  • Table 3. Healthcare CRO Services Clinic Research Services {Phase I, Phase II, Phase III, Phase IV} , by Region USD Million (2015-2020)
  • Table 4. Healthcare CRO Services Laboratory Services {Bioanalytical Testing, Analytical Testing (Physical Characterization, Stability Testing, Batch Release Testing, Raw Material Testing, Other Analytical Testing)} , by Region USD Million (2015-2020)
  • Table 5. Healthcare CRO Services Consulting Services , by Region USD Million (2015-2020)
  • Table 6. Healthcare CRO Services Data Management Services , by Region USD Million (2015-2020)
  • Table 7. Healthcare CRO Services: by Therapeutic Areas(USD Million)
  • Table 8. Healthcare CRO Services Oncology , by Region USD Million (2015-2020)
  • Table 9. Healthcare CRO Services CNS Disorder , by Region USD Million (2015-2020)
  • Table 10. Healthcare CRO Services Cardiovascular Disease , by Region USD Million (2015-2020)
  • Table 11. Healthcare CRO Services Metabolic Disease , by Region USD Million (2015-2020)
  • Table 12. Healthcare CRO Services Infectious Disease , by Region USD Million (2015-2020)
  • Table 13. Healthcare CRO Services Immunological Disorders , by Region USD Million (2015-2020)
  • Table 14. Healthcare CRO Services Respiratory Disorders , by Region USD Million (2015-2020)
  • Table 15. Healthcare CRO Services Diabetes , by Region USD Million (2015-2020)
  • Table 16. Healthcare CRO Services Other , by Region USD Million (2015-2020)
  • Table 17. Healthcare CRO Services: by End User(USD Million)
  • Table 18. Healthcare CRO Services Pharmaceutical and Biopharmaceutical Companies , by Region USD Million (2015-2020)
  • Table 19. Healthcare CRO Services Medical Device Companies , by Region USD Million (2015-2020)
  • Table 20. Healthcare CRO Services Academic Institutes , by Region USD Million (2015-2020)
  • Table 21. South America Healthcare CRO Services, by Country USD Million (2015-2020)
  • Table 22. South America Healthcare CRO Services, by Type USD Million (2015-2020)
  • Table 23. South America Healthcare CRO Services, by Therapeutic Areas USD Million (2015-2020)
  • Table 24. South America Healthcare CRO Services, by End User USD Million (2015-2020)
  • Table 25. Brazil Healthcare CRO Services, by Type USD Million (2015-2020)
  • Table 26. Brazil Healthcare CRO Services, by Therapeutic Areas USD Million (2015-2020)
  • Table 27. Brazil Healthcare CRO Services, by End User USD Million (2015-2020)
  • Table 28. Argentina Healthcare CRO Services, by Type USD Million (2015-2020)
  • Table 29. Argentina Healthcare CRO Services, by Therapeutic Areas USD Million (2015-2020)
  • Table 30. Argentina Healthcare CRO Services, by End User USD Million (2015-2020)
  • Table 31. Rest of South America Healthcare CRO Services, by Type USD Million (2015-2020)
  • Table 32. Rest of South America Healthcare CRO Services, by Therapeutic Areas USD Million (2015-2020)
  • Table 33. Rest of South America Healthcare CRO Services, by End User USD Million (2015-2020)
  • Table 34. Asia Pacific Healthcare CRO Services, by Country USD Million (2015-2020)
  • Table 35. Asia Pacific Healthcare CRO Services, by Type USD Million (2015-2020)
  • Table 36. Asia Pacific Healthcare CRO Services, by Therapeutic Areas USD Million (2015-2020)
  • Table 37. Asia Pacific Healthcare CRO Services, by End User USD Million (2015-2020)
  • Table 38. China Healthcare CRO Services, by Type USD Million (2015-2020)
  • Table 39. China Healthcare CRO Services, by Therapeutic Areas USD Million (2015-2020)
  • Table 40. China Healthcare CRO Services, by End User USD Million (2015-2020)
  • Table 41. Japan Healthcare CRO Services, by Type USD Million (2015-2020)
  • Table 42. Japan Healthcare CRO Services, by Therapeutic Areas USD Million (2015-2020)
  • Table 43. Japan Healthcare CRO Services, by End User USD Million (2015-2020)
  • Table 44. India Healthcare CRO Services, by Type USD Million (2015-2020)
  • Table 45. India Healthcare CRO Services, by Therapeutic Areas USD Million (2015-2020)
  • Table 46. India Healthcare CRO Services, by End User USD Million (2015-2020)
  • Table 47. South Korea Healthcare CRO Services, by Type USD Million (2015-2020)
  • Table 48. South Korea Healthcare CRO Services, by Therapeutic Areas USD Million (2015-2020)
  • Table 49. South Korea Healthcare CRO Services, by End User USD Million (2015-2020)
  • Table 50. Taiwan Healthcare CRO Services, by Type USD Million (2015-2020)
  • Table 51. Taiwan Healthcare CRO Services, by Therapeutic Areas USD Million (2015-2020)
  • Table 52. Taiwan Healthcare CRO Services, by End User USD Million (2015-2020)
  • Table 53. Australia Healthcare CRO Services, by Type USD Million (2015-2020)
  • Table 54. Australia Healthcare CRO Services, by Therapeutic Areas USD Million (2015-2020)
  • Table 55. Australia Healthcare CRO Services, by End User USD Million (2015-2020)
  • Table 56. Rest of Asia-Pacific Healthcare CRO Services, by Type USD Million (2015-2020)
  • Table 57. Rest of Asia-Pacific Healthcare CRO Services, by Therapeutic Areas USD Million (2015-2020)
  • Table 58. Rest of Asia-Pacific Healthcare CRO Services, by End User USD Million (2015-2020)
  • Table 59. Europe Healthcare CRO Services, by Country USD Million (2015-2020)
  • Table 60. Europe Healthcare CRO Services, by Type USD Million (2015-2020)
  • Table 61. Europe Healthcare CRO Services, by Therapeutic Areas USD Million (2015-2020)
  • Table 62. Europe Healthcare CRO Services, by End User USD Million (2015-2020)
  • Table 63. Germany Healthcare CRO Services, by Type USD Million (2015-2020)
  • Table 64. Germany Healthcare CRO Services, by Therapeutic Areas USD Million (2015-2020)
  • Table 65. Germany Healthcare CRO Services, by End User USD Million (2015-2020)
  • Table 66. France Healthcare CRO Services, by Type USD Million (2015-2020)
  • Table 67. France Healthcare CRO Services, by Therapeutic Areas USD Million (2015-2020)
  • Table 68. France Healthcare CRO Services, by End User USD Million (2015-2020)
  • Table 69. Italy Healthcare CRO Services, by Type USD Million (2015-2020)
  • Table 70. Italy Healthcare CRO Services, by Therapeutic Areas USD Million (2015-2020)
  • Table 71. Italy Healthcare CRO Services, by End User USD Million (2015-2020)
  • Table 72. United Kingdom Healthcare CRO Services, by Type USD Million (2015-2020)
  • Table 73. United Kingdom Healthcare CRO Services, by Therapeutic Areas USD Million (2015-2020)
  • Table 74. United Kingdom Healthcare CRO Services, by End User USD Million (2015-2020)
  • Table 75. Netherlands Healthcare CRO Services, by Type USD Million (2015-2020)
  • Table 76. Netherlands Healthcare CRO Services, by Therapeutic Areas USD Million (2015-2020)
  • Table 77. Netherlands Healthcare CRO Services, by End User USD Million (2015-2020)
  • Table 78. Rest of Europe Healthcare CRO Services, by Type USD Million (2015-2020)
  • Table 79. Rest of Europe Healthcare CRO Services, by Therapeutic Areas USD Million (2015-2020)
  • Table 80. Rest of Europe Healthcare CRO Services, by End User USD Million (2015-2020)
  • Table 81. MEA Healthcare CRO Services, by Country USD Million (2015-2020)
  • Table 82. MEA Healthcare CRO Services, by Type USD Million (2015-2020)
  • Table 83. MEA Healthcare CRO Services, by Therapeutic Areas USD Million (2015-2020)
  • Table 84. MEA Healthcare CRO Services, by End User USD Million (2015-2020)
  • Table 85. Middle East Healthcare CRO Services, by Type USD Million (2015-2020)
  • Table 86. Middle East Healthcare CRO Services, by Therapeutic Areas USD Million (2015-2020)
  • Table 87. Middle East Healthcare CRO Services, by End User USD Million (2015-2020)
  • Table 88. Africa Healthcare CRO Services, by Type USD Million (2015-2020)
  • Table 89. Africa Healthcare CRO Services, by Therapeutic Areas USD Million (2015-2020)
  • Table 90. Africa Healthcare CRO Services, by End User USD Million (2015-2020)
  • Table 91. North America Healthcare CRO Services, by Country USD Million (2015-2020)
  • Table 92. North America Healthcare CRO Services, by Type USD Million (2015-2020)
  • Table 93. North America Healthcare CRO Services, by Therapeutic Areas USD Million (2015-2020)
  • Table 94. North America Healthcare CRO Services, by End User USD Million (2015-2020)
  • Table 95. United States Healthcare CRO Services, by Type USD Million (2015-2020)
  • Table 96. United States Healthcare CRO Services, by Therapeutic Areas USD Million (2015-2020)
  • Table 97. United States Healthcare CRO Services, by End User USD Million (2015-2020)
  • Table 98. Canada Healthcare CRO Services, by Type USD Million (2015-2020)
  • Table 99. Canada Healthcare CRO Services, by Therapeutic Areas USD Million (2015-2020)
  • Table 100. Canada Healthcare CRO Services, by End User USD Million (2015-2020)
  • Table 101. Mexico Healthcare CRO Services, by Type USD Million (2015-2020)
  • Table 102. Mexico Healthcare CRO Services, by Therapeutic Areas USD Million (2015-2020)
  • Table 103. Mexico Healthcare CRO Services, by End User USD Million (2015-2020)
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Company Basic Information, Sales Area and Its Competitors
  • Table 111. Company Basic Information, Sales Area and Its Competitors
  • Table 112. Company Basic Information, Sales Area and Its Competitors
  • Table 113. Company Basic Information, Sales Area and Its Competitors
  • Table 114. Company Basic Information, Sales Area and Its Competitors
  • Table 115. Company Basic Information, Sales Area and Its Competitors
  • Table 116. Company Basic Information, Sales Area and Its Competitors
  • Table 117. Healthcare CRO Services: by Type(USD Million)
  • Table 118. Healthcare CRO Services Early Phase Development Services {Discovery Studies, Chemistry, Manufacturing & Control, Preclinical Services (Pharmacokinetics /Pharmacodynamics, Toxicology Testing, Other) , by Region USD Million (2021-2026)
  • Table 119. Healthcare CRO Services Clinic Research Services {Phase I, Phase II, Phase III, Phase IV} , by Region USD Million (2021-2026)
  • Table 120. Healthcare CRO Services Laboratory Services {Bioanalytical Testing, Analytical Testing (Physical Characterization, Stability Testing, Batch Release Testing, Raw Material Testing, Other Analytical Testing)} , by Region USD Million (2021-2026)
  • Table 121. Healthcare CRO Services Consulting Services , by Region USD Million (2021-2026)
  • Table 122. Healthcare CRO Services Data Management Services , by Region USD Million (2021-2026)
  • Table 123. Healthcare CRO Services: by Therapeutic Areas(USD Million)
  • Table 124. Healthcare CRO Services Oncology , by Region USD Million (2021-2026)
  • Table 125. Healthcare CRO Services CNS Disorder , by Region USD Million (2021-2026)
  • Table 126. Healthcare CRO Services Cardiovascular Disease , by Region USD Million (2021-2026)
  • Table 127. Healthcare CRO Services Metabolic Disease , by Region USD Million (2021-2026)
  • Table 128. Healthcare CRO Services Infectious Disease , by Region USD Million (2021-2026)
  • Table 129. Healthcare CRO Services Immunological Disorders , by Region USD Million (2021-2026)
  • Table 130. Healthcare CRO Services Respiratory Disorders , by Region USD Million (2021-2026)
  • Table 131. Healthcare CRO Services Diabetes , by Region USD Million (2021-2026)
  • Table 132. Healthcare CRO Services Other , by Region USD Million (2021-2026)
  • Table 133. Healthcare CRO Services: by End User(USD Million)
  • Table 134. Healthcare CRO Services Pharmaceutical and Biopharmaceutical Companies , by Region USD Million (2021-2026)
  • Table 135. Healthcare CRO Services Medical Device Companies , by Region USD Million (2021-2026)
  • Table 136. Healthcare CRO Services Academic Institutes , by Region USD Million (2021-2026)
  • Table 137. South America Healthcare CRO Services, by Country USD Million (2021-2026)
  • Table 138. South America Healthcare CRO Services, by Type USD Million (2021-2026)
  • Table 139. South America Healthcare CRO Services, by Therapeutic Areas USD Million (2021-2026)
  • Table 140. South America Healthcare CRO Services, by End User USD Million (2021-2026)
  • Table 141. Brazil Healthcare CRO Services, by Type USD Million (2021-2026)
  • Table 142. Brazil Healthcare CRO Services, by Therapeutic Areas USD Million (2021-2026)
  • Table 143. Brazil Healthcare CRO Services, by End User USD Million (2021-2026)
  • Table 144. Argentina Healthcare CRO Services, by Type USD Million (2021-2026)
  • Table 145. Argentina Healthcare CRO Services, by Therapeutic Areas USD Million (2021-2026)
  • Table 146. Argentina Healthcare CRO Services, by End User USD Million (2021-2026)
  • Table 147. Rest of South America Healthcare CRO Services, by Type USD Million (2021-2026)
  • Table 148. Rest of South America Healthcare CRO Services, by Therapeutic Areas USD Million (2021-2026)
  • Table 149. Rest of South America Healthcare CRO Services, by End User USD Million (2021-2026)
  • Table 150. Asia Pacific Healthcare CRO Services, by Country USD Million (2021-2026)
  • Table 151. Asia Pacific Healthcare CRO Services, by Type USD Million (2021-2026)
  • Table 152. Asia Pacific Healthcare CRO Services, by Therapeutic Areas USD Million (2021-2026)
  • Table 153. Asia Pacific Healthcare CRO Services, by End User USD Million (2021-2026)
  • Table 154. China Healthcare CRO Services, by Type USD Million (2021-2026)
  • Table 155. China Healthcare CRO Services, by Therapeutic Areas USD Million (2021-2026)
  • Table 156. China Healthcare CRO Services, by End User USD Million (2021-2026)
  • Table 157. Japan Healthcare CRO Services, by Type USD Million (2021-2026)
  • Table 158. Japan Healthcare CRO Services, by Therapeutic Areas USD Million (2021-2026)
  • Table 159. Japan Healthcare CRO Services, by End User USD Million (2021-2026)
  • Table 160. India Healthcare CRO Services, by Type USD Million (2021-2026)
  • Table 161. India Healthcare CRO Services, by Therapeutic Areas USD Million (2021-2026)
  • Table 162. India Healthcare CRO Services, by End User USD Million (2021-2026)
  • Table 163. South Korea Healthcare CRO Services, by Type USD Million (2021-2026)
  • Table 164. South Korea Healthcare CRO Services, by Therapeutic Areas USD Million (2021-2026)
  • Table 165. South Korea Healthcare CRO Services, by End User USD Million (2021-2026)
  • Table 166. Taiwan Healthcare CRO Services, by Type USD Million (2021-2026)
  • Table 167. Taiwan Healthcare CRO Services, by Therapeutic Areas USD Million (2021-2026)
  • Table 168. Taiwan Healthcare CRO Services, by End User USD Million (2021-2026)
  • Table 169. Australia Healthcare CRO Services, by Type USD Million (2021-2026)
  • Table 170. Australia Healthcare CRO Services, by Therapeutic Areas USD Million (2021-2026)
  • Table 171. Australia Healthcare CRO Services, by End User USD Million (2021-2026)
  • Table 172. Rest of Asia-Pacific Healthcare CRO Services, by Type USD Million (2021-2026)
  • Table 173. Rest of Asia-Pacific Healthcare CRO Services, by Therapeutic Areas USD Million (2021-2026)
  • Table 174. Rest of Asia-Pacific Healthcare CRO Services, by End User USD Million (2021-2026)
  • Table 175. Europe Healthcare CRO Services, by Country USD Million (2021-2026)
  • Table 176. Europe Healthcare CRO Services, by Type USD Million (2021-2026)
  • Table 177. Europe Healthcare CRO Services, by Therapeutic Areas USD Million (2021-2026)
  • Table 178. Europe Healthcare CRO Services, by End User USD Million (2021-2026)
  • Table 179. Germany Healthcare CRO Services, by Type USD Million (2021-2026)
  • Table 180. Germany Healthcare CRO Services, by Therapeutic Areas USD Million (2021-2026)
  • Table 181. Germany Healthcare CRO Services, by End User USD Million (2021-2026)
  • Table 182. France Healthcare CRO Services, by Type USD Million (2021-2026)
  • Table 183. France Healthcare CRO Services, by Therapeutic Areas USD Million (2021-2026)
  • Table 184. France Healthcare CRO Services, by End User USD Million (2021-2026)
  • Table 185. Italy Healthcare CRO Services, by Type USD Million (2021-2026)
  • Table 186. Italy Healthcare CRO Services, by Therapeutic Areas USD Million (2021-2026)
  • Table 187. Italy Healthcare CRO Services, by End User USD Million (2021-2026)
  • Table 188. United Kingdom Healthcare CRO Services, by Type USD Million (2021-2026)
  • Table 189. United Kingdom Healthcare CRO Services, by Therapeutic Areas USD Million (2021-2026)
  • Table 190. United Kingdom Healthcare CRO Services, by End User USD Million (2021-2026)
  • Table 191. Netherlands Healthcare CRO Services, by Type USD Million (2021-2026)
  • Table 192. Netherlands Healthcare CRO Services, by Therapeutic Areas USD Million (2021-2026)
  • Table 193. Netherlands Healthcare CRO Services, by End User USD Million (2021-2026)
  • Table 194. Rest of Europe Healthcare CRO Services, by Type USD Million (2021-2026)
  • Table 195. Rest of Europe Healthcare CRO Services, by Therapeutic Areas USD Million (2021-2026)
  • Table 196. Rest of Europe Healthcare CRO Services, by End User USD Million (2021-2026)
  • Table 197. MEA Healthcare CRO Services, by Country USD Million (2021-2026)
  • Table 198. MEA Healthcare CRO Services, by Type USD Million (2021-2026)
  • Table 199. MEA Healthcare CRO Services, by Therapeutic Areas USD Million (2021-2026)
  • Table 200. MEA Healthcare CRO Services, by End User USD Million (2021-2026)
  • Table 201. Middle East Healthcare CRO Services, by Type USD Million (2021-2026)
  • Table 202. Middle East Healthcare CRO Services, by Therapeutic Areas USD Million (2021-2026)
  • Table 203. Middle East Healthcare CRO Services, by End User USD Million (2021-2026)
  • Table 204. Africa Healthcare CRO Services, by Type USD Million (2021-2026)
  • Table 205. Africa Healthcare CRO Services, by Therapeutic Areas USD Million (2021-2026)
  • Table 206. Africa Healthcare CRO Services, by End User USD Million (2021-2026)
  • Table 207. North America Healthcare CRO Services, by Country USD Million (2021-2026)
  • Table 208. North America Healthcare CRO Services, by Type USD Million (2021-2026)
  • Table 209. North America Healthcare CRO Services, by Therapeutic Areas USD Million (2021-2026)
  • Table 210. North America Healthcare CRO Services, by End User USD Million (2021-2026)
  • Table 211. United States Healthcare CRO Services, by Type USD Million (2021-2026)
  • Table 212. United States Healthcare CRO Services, by Therapeutic Areas USD Million (2021-2026)
  • Table 213. United States Healthcare CRO Services, by End User USD Million (2021-2026)
  • Table 214. Canada Healthcare CRO Services, by Type USD Million (2021-2026)
  • Table 215. Canada Healthcare CRO Services, by Therapeutic Areas USD Million (2021-2026)
  • Table 216. Canada Healthcare CRO Services, by End User USD Million (2021-2026)
  • Table 217. Mexico Healthcare CRO Services, by Type USD Million (2021-2026)
  • Table 218. Mexico Healthcare CRO Services, by Therapeutic Areas USD Million (2021-2026)
  • Table 219. Mexico Healthcare CRO Services, by End User USD Million (2021-2026)
  • Table 220. Research Programs/Design for This Report
  • Table 221. Key Data Information from Secondary Sources
  • Table 222. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Healthcare CRO Services: by Type USD Million (2015-2020)
  • Figure 5. Global Healthcare CRO Services: by Therapeutic Areas USD Million (2015-2020)
  • Figure 6. Global Healthcare CRO Services: by End User USD Million (2015-2020)
  • Figure 7. South America Healthcare CRO Services Share (%), by Country
  • Figure 8. Asia Pacific Healthcare CRO Services Share (%), by Country
  • Figure 9. Europe Healthcare CRO Services Share (%), by Country
  • Figure 10. MEA Healthcare CRO Services Share (%), by Country
  • Figure 11. North America Healthcare CRO Services Share (%), by Country
  • Figure 12. Global Healthcare CRO Services share by Players 2020 (%)
  • Figure 13. Global Healthcare CRO Services share by Players (Top 3) 2020(%)
  • Figure 14. Global Healthcare CRO Services share by Players (Top 5) 2020(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. IQVIA Holdings, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 17. IQVIA Holdings, Inc. (United States) Revenue: by Geography 2020
  • Figure 18. Laboratory Corporation of America Holdings (United States) Revenue, Net Income and Gross profit
  • Figure 19. Laboratory Corporation of America Holdings (United States) Revenue: by Geography 2020
  • Figure 20. Pharmaceutical Product Development, Inc.(United States) Revenue, Net Income and Gross profit
  • Figure 21. Pharmaceutical Product Development, Inc.(United States) Revenue: by Geography 2020
  • Figure 22. Parexel International Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 23. Parexel International Corporation (United States) Revenue: by Geography 2020
  • Figure 24. Charles River Laboratories International, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 25. Charles River Laboratories International, Inc. (United States) Revenue: by Geography 2020
  • Figure 26. ICON PLC (Ireland) Revenue, Net Income and Gross profit
  • Figure 27. ICON PLC (Ireland) Revenue: by Geography 2020
  • Figure 28. Medidata Solutions, Inc.(United States) Revenue, Net Income and Gross profit
  • Figure 29. Medidata Solutions, Inc.(United States) Revenue: by Geography 2020
  • Figure 30. Syneos Health, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 31. Syneos Health, Inc. (United States) Revenue: by Geography 2020
  • Figure 32. Pharmaron Beijing Co., Ltd. (China) Revenue, Net Income and Gross profit
  • Figure 33. Pharmaron Beijing Co., Ltd. (China) Revenue: by Geography 2020
  • Figure 34. GVK Biosciences Private Limited (India) Revenue, Net Income and Gross profit
  • Figure 35. GVK Biosciences Private Limited (India) Revenue: by Geography 2020
  • Figure 36. SGS SA (Switzerland) Revenue, Net Income and Gross profit
  • Figure 37. SGS SA (Switzerland) Revenue: by Geography 2020
  • Figure 38. EPS International Co., Ltd (Japan) Revenue, Net Income and Gross profit
  • Figure 39. EPS International Co., Ltd (Japan) Revenue: by Geography 2020
  • Figure 40. Genscript Biotech (United States) Revenue, Net Income and Gross profit
  • Figure 41. Genscript Biotech (United States) Revenue: by Geography 2020
  • Figure 42. Global Healthcare CRO Services: by Type USD Million (2021-2026)
  • Figure 43. Global Healthcare CRO Services: by Therapeutic Areas USD Million (2021-2026)
  • Figure 44. Global Healthcare CRO Services: by End User USD Million (2021-2026)
  • Figure 45. South America Healthcare CRO Services Share (%), by Country
  • Figure 46. Asia Pacific Healthcare CRO Services Share (%), by Country
  • Figure 47. Europe Healthcare CRO Services Share (%), by Country
  • Figure 48. MEA Healthcare CRO Services Share (%), by Country
  • Figure 49. North America Healthcare CRO Services Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • IQVIA Holdings, Inc. (United States)
  • Laboratory Corporation of America Holdings (United States)
  • Pharmaceutical Product Development, Inc.(United States)
  • Parexel International Corporation (United States)
  • Charles River Laboratories International, Inc. (United States)
  • ICON PLC (Ireland)
  • Medidata Solutions, Inc.(United States)
  • Syneos Health, Inc. (United States)
  • Pharmaron Beijing Co., Ltd. (China)
  • GVK Biosciences Private Limited (India)
  • SGS SA (Switzerland)
  • EPS International Co., Ltd (Japan)
  • Genscript Biotech (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation